DE3877630D1 - Transkutane verabreichung von pharmazeutika. - Google Patents

Transkutane verabreichung von pharmazeutika.

Info

Publication number
DE3877630D1
DE3877630D1 DE8888107473T DE3877630T DE3877630D1 DE 3877630 D1 DE3877630 D1 DE 3877630D1 DE 8888107473 T DE8888107473 T DE 8888107473T DE 3877630 T DE3877630 T DE 3877630T DE 3877630 D1 DE3877630 D1 DE 3877630D1
Authority
DE
Germany
Prior art keywords
pharmaceuticals
transcutaneous administration
enantiomers
transcutaneous
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888107473T
Other languages
English (en)
Other versions
DE3877630T2 (de
Inventor
John Michael Pawelchak
James Ronald Lawter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE3877630D1 publication Critical patent/DE3877630D1/de
Application granted granted Critical
Publication of DE3877630T2 publication Critical patent/DE3877630T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8888107473T 1987-06-12 1988-05-10 Transkutane verabreichung von pharmazeutika. Expired - Lifetime DE3877630T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6184287A 1987-06-12 1987-06-12

Publications (2)

Publication Number Publication Date
DE3877630D1 true DE3877630D1 (de) 1993-03-04
DE3877630T2 DE3877630T2 (de) 1993-06-03

Family

ID=22038497

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888107473T Expired - Lifetime DE3877630T2 (de) 1987-06-12 1988-05-10 Transkutane verabreichung von pharmazeutika.

Country Status (16)

Country Link
EP (1) EP0294601B1 (de)
JP (1) JP2654092B2 (de)
KR (1) KR970000506B1 (de)
AT (1) ATE84714T1 (de)
AU (1) AU609142B2 (de)
CA (1) CA1305418C (de)
DE (1) DE3877630T2 (de)
DK (1) DK171746B1 (de)
ES (1) ES2043719T3 (de)
GR (1) GR3006938T3 (de)
IE (1) IE62735B1 (de)
IL (1) IL86334A (de)
NO (1) NO178096C (de)
NZ (1) NZ224891A (de)
PT (1) PT87704B (de)
ZA (1) ZA884186B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin
US5476854A (en) * 1991-11-27 1995-12-19 Sepracor Inc. Methods and compositions for treating bacterial infection using optically pure (R)-lomefloxacin
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
WO1994010986A1 (en) * 1992-11-09 1994-05-26 Pharmetrix Corporation Transdermal delivery of ketorolac
NZ530227A (en) * 2001-06-18 2006-09-29 Noven Pharma Enhanced drug delivery in transdermal systems
DK1628663T3 (da) 2003-05-15 2010-03-08 Roskamp Res Llc Fremgangsmåde til fremstilling af medikamenter til reduktion af amyloid-aflejring, amyloid-neurotoksicitet og mikrogliose
TWI500422B (zh) 2007-10-05 2015-09-21 Alzheimer S Inst Of America Inc 以（－）－尼代地平（ｎｉｌｖａｄｉｐｉｎｅ）對映異構物減低類澱粉沉積、類澱粉神經毒性及微神經膠細胞增生之方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
JPS6016917A (ja) * 1983-07-08 1985-01-28 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンまたはニフエジピンの軟膏剤
JPS60258179A (ja) * 1984-06-04 1985-12-20 Yamanouchi Pharmaceut Co Ltd Ｙｍ−０９７３０のジアステレオマ−ａの右旋性光学異性体またはその酸付加塩，該化合物の製造方法および該化合物からなる医薬
DE3419128A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Dihydropyridinpraeparate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
PT87704B (pt) 1993-03-31
EP0294601A3 (en) 1989-10-11
EP0294601A2 (de) 1988-12-14
NO882559D0 (no) 1988-06-10
ES2043719T3 (es) 1994-01-01
IL86334A (en) 1992-09-06
AU609142B2 (en) 1991-04-26
DK316788A (da) 1988-12-13
JP2654092B2 (ja) 1997-09-17
CA1305418C (en) 1992-07-21
KR890000090A (ko) 1989-03-11
IE62735B1 (en) 1995-02-22
EP0294601B1 (de) 1993-01-20
DE3877630T2 (de) 1993-06-03
NZ224891A (en) 1992-06-25
JPS6413024A (en) 1989-01-17
GR3006938T3 (de) 1993-06-30
ATE84714T1 (de) 1993-02-15
DK316788D0 (da) 1988-06-10
NO178096B (no) 1995-10-16
PT87704A (pt) 1988-07-01
NO178096C (no) 1996-01-24
IE881749L (en) 1988-12-12
NO882559L (no) 1988-12-13
AU1761088A (en) 1988-12-15
KR970000506B1 (ko) 1997-01-13
DK171746B1 (da) 1997-05-05
ZA884186B (en) 1989-03-29

Similar Documents

Publication Publication Date Title
DE3688075D1 (de) Transdermales verabreichungssystem.
FI895681A0 (fi) Farmaceutisk komposition foer systemisk transdermal tillfoersel.
DE3751761D1 (de) Penetrationsverbesserer für die transdermale Verabreichung von systemisch wirksamen Arzneimitteln
DE3789320D1 (de) Verabreichungsinstrument zum Einführen von festen Medikamenten.
DE69129861D1 (de) Topische mittel zur transdermalen verabreichung von prodrugderivaten des morphins
FI961809A (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
DE69429603D1 (de) Iontophoresematrix
ATE56138T1 (de) Perfluorkohlenwasserstoffe als vehikel zur verabreichung von arzneimitteln.
ATE98876T1 (de) Pharmazeutische praeparate.
SE8404065D0 (sv) Novel biologically active compounds
ATE84714T1 (de) Transkutane verabreichung von pharmazeutika.
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
ATE200617T1 (de) Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge
ATE100465T1 (de) Analoge von bradykinin, dessen synthese und dessen benutzung in der therapie.
ES2019634B3 (es) Terapia con clorfeniramina.
ATE20230T1 (de) Spasmolytisch wirksames (+)s-enantiomer von secoverin.
ATE81971T1 (de) Synergistische kombination von decarboxylasehemmern und l-dopa-pellets.
ATE84975T1 (de) Pharmazeutische praeparate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WYETH HOLDINGS CORP., MADISON, N.J., US